| | Call Details | ATS Medical Earnings Conference Call (Q1 2008) Mon,
May 5, 2008, 5:00 pm Eastern
| | About ATS Medical
(NasdaqGM:ATSI) |
| | ATS Medical, Inc. engages in the development, manufacture, and marketing of medical devices for the treatment of structural heart disease. It offers prosthetic heart valves, such as ATS Open Pivot Heart Valve, a mechanical heart valve, as well as ATS 3F Aortic Bioprosthesis, a biological replacement aortic heart valve; and heart valve repair products, such as ATS Simulus Flexible annuloplasty repair rings and bands, ATS Simulus Semi-Rigid Annuloplasty Ring, and ATS Simulus Adjustable repair rings. The company also markets and sells surgical cryotherapy products, including the ATS CryoMaze Surgical Ablation Probe, the ATS FrostByte Surgical Ablation Clamp, and the ATS CryoMaze Surgical Ablation Console. In addition, it is developing minimally invasive and off-pump aortic valve concepts, such as ATS 3F Enable Aortic Heart Valve and ATS Entrata Aortic Valve System. The company markets and sells its products to hospitals in the United States, the United Kingdom, France, Germany, Belgium, the Netherlands, and Switzerland; and to independent distributors internationally. ATS Medical, Inc. was founded in 1987 and is based in Minneapolis, Minnesota. |
| More
Info:
Quote
|
Chart
|
News
|
Profile
|
Reports
|
Research
|
SEC
|
Msgs
|
Insider
|
Financials
|
Analyst Ratings |
|